Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc. is a biopharmaceutical company specializing in immuno-oncology therapies. They develop novel cancer treatments and have a robust pipeline of drug candidates. Recently acquired by Sun Pharma, they continue to advance innovative therapies to improve patient outcomes.